Patent details

EP3325468 Title: CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS

Basic Information

Publication number:
EP3325468
PCT Application Number:
US2016042529
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167450055
PCT Publication Number:
WO2017015124
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
French Title of Invention:
UTILISATION D'INHIBITEURS DE CHK1/2 DANS LE TRAITEMENT DE NEUROBLASTOMES ET/OU DE SARCOMES DES TISSUS MOUS
German Title of Invention:
CHK1/2-INHIBITOREN ZUR BEHANDLUNG VON NEUROBLASTOMEN UND/ODER WEICHGEWEBESARKOMEN
SPC Number:

Dates

Filing date:
15/07/2016
Grant date:
11/11/2020
EP Publication Date:
30/05/2018
PCT Publication Date:
26/01/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2020
EP B1 Publication Date:
11/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/07/2021
Expiration date:
15/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/11/2020
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

Name:
STANCATO, Louis Frank
Address:
United States (US)

Priority

1

Priority Number:
201562196087 P
Priority Date:
23/07/2015
Priority Country:
United States (US)

2

Priority Number:
201562248408 P
Priority Date:
30/10/2015
Priority Country:
United States (US)

3

Priority Number:
201562264059 P
Priority Date:
07/12/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4155; A61P 35/00; C07D 403/12;

Publication

European Patent Bulletin

Issue number:
202046
Publication date:
11/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages